Issuu

L I F E H E A LT H C A R E

A mission to improve access to medical servicesÂ

L I F E

H E A LT H C A R E

Breathing Life into SA Healthcare and beyond Life Healthcare is opening up access to quality, life changing healthcare services across the whole of South Africa and parts of Europe. Group CEO Shrey Viranna reveals how Writer: Tom Wadlow | Project Manager: Callam Waller

uality healthcare delivery, quality patient experience and efficient operations built on strong partnerships – these are the hallmarks of the Life Healthcare Group, a market-leading, diversified and international healthcare provider. Operating with a core purpose of making life better and improving the lives of others, the Group’s mission is to improve lives through the delivery of high quality care and cost-effective services for patients. These services are underpinned by a set of core values. They include a passion for people, quality to the power of ‘e’ (ethics, excellence, empowerment, empathy and energy), performance pride, personal care and lifetime partnerships. The Life Healthcare Group believes that caring for patients stretches beyond simply healing and recovery. It also involves building empathetic relationships with the people who use its hospitals, facilities, services and products.

An ever-present business

These values and beliefs have shaped the organisation’s identity as it has

evolved over more than three decades. As a result, the Life Healthcare Group is well-positioned to contribute to the advancement of South Africa’s wider healthcare industry as well as that of western Europe and Poland. The Group operates 65 hospitals and healthcare facilities throughout South Africa and Botswana, a presence that is complemented by a portfolio of mental health, acute rehabilitation,

Dr Shrey Viranna, Group CEO

WWW.AFRICAOUTLOOKMAG.COM

renal dialysis, oncology and employee health solutions. This comprehensive footprint was established with origins stretching back to 1983 when, what is today known as the Life Healthcare Group, was founded as the hospitals division of African Oxygen Limited (Afrox). The Group’s CEO, Dr Shrey Viranna, talks through some of the key milestones in the Life Healthcare Group’s history. “In 1997, for the first time, Life Healthcare expanded operations outside South Africa by acquiring the Gaborone Hospital in Botswana,” he says. “A year later we began our diversification into complementary health services with the acquisition of Afrox Occupational Health Care, followed by the opening of Life Healthcare’s first rehabilitation, mental health and renal dialysis units in the major centres around South Africa.” The Group’s growth continued with the acquisition of Presmed’s 38 hospitals and healthcare facilities through a merger and reverse listing on the Johannesburg Stock Exchange in 1999. This was followed by the purchase of the Amahosp Group and the acquisition of a 55 percent share in Life Esidimeni.

WWW.AFRICAOUTLOOKMAG.COM

It’s not just a generic, it’s an Adcock Ingram Generic For more information on our brands please contact: info@adcock.com or go to www.adcock.com Adcock Ingram Limited. Reg. No. 1949/034385/06. Private Bag X69, Bryanston, 2021, South Africa. Telephone + 27 11 635 0000. www.adcock.com. 2018102410105368.

YEARS OF TRUSTED MEDICINES QUALITY& EFFICACY

AFFORDABLE

PROUDLY SOUTH AFRICAN

L I F E

H E A L T H C A R E

In 2005, the Group delisted, and was sold to a private consortium led by Brimstone and Mvelaphanda, which saw the name change from Afrox Healthcare to the Life Healthcare Group. After listing on the JSE in 2010, the Group’s diversification continued with the acquisition of Careways, an established health and wellness business. “Over the past 35 years, Life Healthcare has built a strong brand anchored in the delivery of quality healthcare and patient experience, efficient operations, strong partnerships and making a meaningful contribution began with the acquisition of a stake to society and the communities we in major Indian hospital group Max serve,” adds Dr Viranna. Healthcare in 2013. However, this shareholding has since been sold as Diversification drive an element of the strategic evolution The Life Healthcare Group further in emerging markets from delivering strengthened its expertise through acute hospital care to providing acquisitions and ventures into new integrated healthcare. markets and territories, tapping into Subsequent to the Group’s venture the likes of India, the United Kingdom into India, it also acquired Poland’s (UK) and Poland. This diversification Scanmed S.A., a private healthcare

WWW.AFRICAOUTLOOKMAG.COM

Life Healthcare operates 65 facilities across South Africa and Botswana

provider which operates in 40 locations across 23 cities, as well as UK-based Alliance Medical Group (AMG), a leading independent provider of diagnostic imaging services, with operations in 10 European countries. The acquisition of AMG has proven to be a vital component in the Life Healthcare Group’s international strategy and has a “strong, highly complementary management

It’s not just a generic. It’s an Adcock Ingram Generic. Adcock Ingram has a proud heritage which spans over more than 125 years, and strives to bring you effective, quality generic medication in a wide range of disease areas. Our product list includes treatments for the most commonly occurring diseases and disorders and we have several generics that have become leaders in the generic category.¹ Adcock Ingram Generics have been subjected to the same strict approval processes by South African medication regulatory authorities as the original medication, to ensure that the generic is as effective, safe and of the same quality as the originator medicine. This is to ensure that your generic is just as good as the originator, but with the added benefit that it is more affordable.²a,b,³a,b

What is a generic medicine? A generic medicine contains the same active ingredient/s and has the same dose strength as the original medicine.²a Because generic medicines work in the same way in the body, they are interchangeable and used in place of original brand name medicines.⁴a,³a Generic medicines are subject to the same stringent controls as original branded products. In fact branded and generic medicines are sometimes made by the same company.⁴a References: 1. IMS TPM MAT Data, December 2018. 2. Black GS. Guidelines for the responsible use of generic medicines [brochure]. Pharmaceutical Society of South Africa. 3. Generic medicines, frequently asked questions [online]. Southern African Generic Medicines Association. 2015 [cited 2018 Oct 31]; Available from: https://www.sagma.net/About-SAGMA/ faq.html. 4. Generic medicines [online]. National Association of Pharmaceutical Manufacturing. 2014 [cited 2018 Oct 31]; Available from: http://napm.co.za/generic-medicines/

Why choose a generic medicine? • Generics offer substantial cost savings without compromising on efficacy²c • Greater savings allow more efficient use of your medical aid benefits²c • Greater savings also frees up money to pay for other, more expensive treatments and services that you may need³b • Lower priced medicines encourage more healthy competition in the market²c • Generics offer you the opportunity to exercise your rights as a consumer²c It is now mandatory by law for a doctor or pharmacist to inform you if a generic medication is available for the medication prescribed to you.⁴e The power of choice of generic medication still resides with you. Adcock Ingram Generics is proud to be associated with Life Healthcare in the supply of quality generic medicines in their endeavour to making life better for patients. Life Healthcare is dedicated to compassionate care, clinical excellence, quality service and a spirit of giving to those entrusted into their care. When choosing a generic, make sure it’s not any generic, but an Adcock Ingram Generic.

T + 27 11 635 0000

www.adcock.com

INSPIRED TO INVENT, A QUEST TO CURE At MSD, we see ourselves as a company inspired to invent. We’re on a quest for cures – that’s our calling. More than a century after our founding, we are engaged in a grand undertaking built on the simple premise that great medicines can still change the world. And we believe that a research‐driven enterprise dedicated to world‐class science can succeed by creating medicines and vaccines that make a difference for patients and society again and again. In our laboratories, MSD scientists work relentlessly to discover solutions to devastating diseases like cancer, Alzheimer’s, and cardio‐metabolic disease. We prevent illness by developing and manufacturing vaccines that allow children to grow up free from the fear of diseases like measles, mumps, chickenpox and rubella. And we invent revolutionary treatments for some of the world’s greatest health challenges, including infectious diseases, HIV and hepatitis C. We push the boundaries of science with the hope and expectation that advancing human knowledge will lead to major

1987 We announced our donation of MECTIZAN® (ivermectin) for the treatment of river blindness, to all who needed it, for as long as needed 2

CERVICAL CANCER We are addressing one of the most common cancers for women in sub-Saharan Africa through sustainable access to our quadrivalent HPV vaccine and partnerships with the First Ladies of Africa 2

advances in human health. And while our commitment to life‐saving science is at the heart of MSD’s business, our scientists are not the only people at MSD who are inspired to invent. Every day, in every business, function, and country in which we operate, our colleagues are finding new ways to bring our medicines and vaccines to more people around the world than ever before. Today, every MSD employee is building on a legacy of invention that goes back more than 125 years – a legacy that extends from the isolation and largescale synthesis of vitamins; to the development of sulfa drugs, antibiotics, and hormones; to the discovery of breakthrough vaccines. As we strive to carry that legacy into the next century and beyond, our values and vision remain true to the words of our modernday founder, George W. Merck: “We try never to forget that medicine is for the people. It is not for the profits. The profits follow, and if we have remembered that, they have never failed to appear.” Guided by this philosophy, our work has changed the world in ways George

2 BILLION TREATMENTS Total global donations to address river blindness and lymphatic filariasis in Africa 2

W. Merck could never have imagined. With the help of MSD, HIV has become a manageable chronic disease rather than a death sentence. With the help of MSD, many countries and entire generations are now free from river blindness. With the help of MSD, millions of children around the world have gone on to become adults, with children of their own. The world with MSD is a very different place than it might otherwise have been. It’s a healthier and more hopeful world – and one we aspire to make healthier and more hopeful still. And so, in our determination to discover, develop, and deliver medicines and vaccines that will improve the lives of more people in more places around the world, we see MSD as more than one of the world’s premier biopharmaceutical companies. Our scientists are pioneers on the frontier of medical progress. Our people are inspired to invent and innovate. We are parents and siblings, partners and spouses, patients and caretakers. And we’re on a quest to cure.1

INNOVATIVE PARTNERSHIPS In support of the Global Strategy for Women’s, Children’s and Adolescents’ health and Kenya’s Beyond Zero campaign. MSD and its partners launched a innovative public-private partnership in September 2015 to harness private-sector collective action in six counties in Kenya 2

1960

30 YEARS

50 %

Our first local production facility opened in Johannesburg 1960 2

How long MSD has been researching solutions to address HIV/AIDS 2

Reduction of the cost of our reversible contraceptive implants for women in 70 of the world’s poorest countries through 2023 2

EBOLA VACCINE Research from the World Health Organization (WHO), the Norwegian Institute of Public Health and the Health Ministry of Guinea found our vaccines candidate is the only candidate showing efﬁcacy in an interim analysis of data from an ongoing Phase III trial in Guinea. At the World Economic Forum 2016 in Davos, Switzerland, MSD announced an advance purchase commitment of the vaccine with Gavi to protect against future deadly Ebola outbreaks 2,3

MSD INVENTING FOR LIFE MSD VISION To make a difference in the lives of people globally through our innovative medicines, vaccines, and animal health products. We are committed to being the premier, researchintensive biopharmaceutical company and are dedicated to providing leading innovations and solutions for today and the future 4

ANAESTHESIA

ANTIINFECTIVES

CARDIOLOGY

ENDOCRINOLOGY E NDOCRINOLOGY

MSD MISSION To discover, develop and provide innovative products and services that save and improve lives around the world 4

HIV

ONCOLOGY

PAIN

REFERENCES: 1. MSD Corporate Narrative 2016. 2. Access to Health in Africa Brochure 2016. 3. http://www.who.int/ csr/resources/publications/ebola/sage-vaccines-2017/en/. 4. https://www.merck.com/about/home.html.

RESPIRATORY VACCINES

MSD (Pty) Ltd (Reg. No. 1996/003791/07), Private Bag 3, Halfway House 1685 Copyright © 2018 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. All rights reserved. CORP-1257996-0004 11/23

WOMEN’S HEALTH

L I F E

H E A L T H C A R E

team with a wealth of healthcare experience, which is helping support our international growth strategy,” Dr Viranna says. The Group’s expansion did not end there. “Over the past year, we have continued to grow AMG through the acquisitions of Albaro Clinic, IMED and Centro Alfa in Italy, as well as Radiopharma and Piramal Imaging S.A. in other parts of Europe,” Dr Viranna continues. “We also started rolling out an outpatient diagnostic clinic model in Ireland.” Dr Viranna’s vision for the Life Healthcare Group is to increase the revenue sourced from international markets to 50 percent in the medium term, an ambition which will also deliver benefits closer to home. This consistent acquisition of knowledge will, crucially, help to better provide for the needs of the South African market. “This is our first substantial foray into the diagnostics market which, due to aging demographics and increasing demand, shows good potential for

growth both internationally and in South Africa,” comments the Group CEO.

Making life better

Dr Viranna joined the Life Healthcare Group approximately 12 months ago. “When the door opened to serve as Life Healthcare’s Group CEO, I felt that this was the logical next step on my journey,” he says. “Life Healthcare’s

WWW.AFRICAOUTLOOKMAG.COM

purpose is ‘making life better’ and our mission is ‘to improve the lives of others through the delivery of high-quality cost-effective care’ – both of which are a perfect fit with the purpose of my own life.” Dr Viranna’s career has always been rooted in healthcare, which includes a 12-year term at McKinsey & Co where he gained extensive international exposure working in East and

WWW.AFRICAOUTLOOKMAG.COM

Global healthcare company Fresenius Kabi collaborates with Life Healthcare Hospital Group to optimise sustainable waste management in a South African hospital environment.

resenius Kabi specialises in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Fresenius Kabi South Africa celebrates its 20th anniversary milestone in March 2019¹. Through its long history, Fresenius Kabi has been driven by excellence in product quality and continues to provide essential medicines and technologies to healthcare professionals, supporting them to overcome daily challenges faced in the treatment of critically and chronically ill patients¹. Their product portfolio comprises of a comprehensive range of I.V. generic medicines, infusion therapies and clinical nutrition products as well as medical devices for administering these products¹. Operating in an age of increased environmental awareness, the pharmaceutical industry like many others is searching for ways to become more ecologically responsible¹. One being to move away from the use of PVC products due to the potentially harmful effects of DEHP (Di(2-ethylhexyl)phthalate) on patients and the environment¹. Fresenius Kabi is committed to being a responsible healthcare company and to provide effective solutions for their customers and patients. In line with this responsibility, Fresenius Kabi has pioneered the manufacturing of freeflex® intravenous fluid containers which are PVC-free and DEHP-free since 2011 in South Africa¹. Considering the extensive use of PVC-free and DEHP-free freeflex® intravenous fluid containers and its packaging in a hospital setting, Fresenius Kabi South Africa embarked on an extensive investigation

into the improvement of waste management processes and options¹. It has been with much excitement that this investigation has led to the pilot phase of a sustainable medical waste programme implemented in 2018. This programme effectively sterilises and converts the PVC-free and DEHP-free freeflex® intravenous fluid containers and its packaging to 50 percent of the original weight and 70 percent of the original volume¹. The resultant by-product is correctly disposed of according to current legislation². As the products do not contain PVC, there are substantially reduced harmful environmental effects compared to PVCcontaining waste, such as leaching of DEHP¹,³. This pilot project was made possible through Life Healthcare a leading private hospital group in South Africa. Sustainability and an emphasis on the environment forms an integral part of Life Healthcare’s values. This shared drive to optimise waste removal in the hospital setting, has created a renewed energy and passionate commitment amongst the staff partaking in the programme, as well as both companies as a whole⁴. Both companies look forward to continuing their commitment of responsibility to patients, the environment and their customers’ needs. This is envisaged through further studies into, as well as the expansion of, the sustainable waste programme. References: 1 Fresenius Kabi data on file. 2 National Environmental Management Waste Act 59 of 2008. 3 Health Care Without Harm. Why Health Care is Moving Away From Hazardous Plastic Polyvinyl Chloride (PVC). 6 April 2006. 4 https://www.lifehealthcare.co.za/about-us/ last accessed 19/11/2018.

L I F E

H E A L T H C A R E

BOSTON SCIENTIFIC About Boston Scientific Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

Southern Africa, India and the UK. His altruistic nature stems from his family upbringing, in particular the influence of his mother. “She devoted her entire life to providing healthcare services to rural communities in KwaZulu-Natal,” he says. “I believe that is part of the reason why I have always had this deep sense of an obligation to improve society. What really excites me are the opportunities that the future of healthcare holds and, further, how we can positively impact the lives of more people and help deliver on new healthcare models to benefit the people of South Africa.” Today, Dr Viranna leads an organisation that is uniquely placed to do just this. Not only does the Life Healthcare Group provide the full spectrum of healthcare, it also operates with a single-minded focus on patients. “Patient centricity and compassion lie at the heart of everything we do,” Dr Viranna

explains, “and this is emphasised through our dedication to patient wellbeing, clinical excellence, quality service, respect and a spirit of giving to those entrusted to our care.” In support of this commitment to delivering quality care, the Life Healthcare Group is the first hospital group in South Africa to have obtained

WWW.AFRICAOUTLOOKMAG.COM

Boston Scientiﬁc In EMEA Who we are Boston Scientiﬁc (NYSE: BSX) is a leading global healthcare company.

Our mission

Have a revenue of

We employ approximately

$9 billion worldwide

29,000 employees worldwide

Boston Scientiﬁc is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.

Our core values

Caring

High Performance

Diversity

Meaningful Innovation 0

-1

Where do we operate

Global Collaboration

Winning Spirit +8

Europe, Middle East, Africa (around EMEA) Northern Cluster Central Western Cluster Southern Cluster Eastern Cluster

European Centre of Operation: Kerkrade (Netherlands) +5

EMEA EHQ: Paris (France)

Growth Emerging Markets

We have commercial representation

+2 -1

We employ

in approximately

2,000

70 Countries

People

Eric Thépaut, Senior Vice President and President, EMEA For a complete list of the EMEA management, please refer to the www.bostonscientiﬁc.com/ en-EU/about-us/european-management.html

2017 EMEA performance

2017 sales by product category

4 in %

Northern Europe Central Western Europe Southern Europe Eastern Europe Growth Emerging Markets

in %

26 13

Cardiovascular Interventional Cardiology Peripheral Interventions Rhythm Management Cardiac Rhythm Management Electrophysiology Endoscopy MedSurg Urology and Pelvic Health Neuromodulation

Our digital presence

2$ Bn revenue (1/4 of worldwide revenue)

What we do

EMEA leadership

2017 sales by cluster

+2.5

www.bostonscientific.eu www.bostonscientific.de www.bostonscientific.es

+4.5 +6

+1 +2

Peripheral Interventions

Neuromodulation

Minimally invasive treatments for peripheral artery, venous disease and cancer.

Electronic implantable technologies that help patients manage debilitating chronic pain and neurological diseases.

Interventional Cardiology

Rhythm Management

Minimally invasive technologies for diagnosing and treating a variety of heart and vascular conditions.

Groundbreaking technologies that treat irregular heart rhythms and heart failure and help protect against sudden cardiac arrest.

Urology and pelvic health

Endoscopy

Industry-leading solutions for urological, urogynaecological and gynaecological diseases

Industry leader in less invasive devices for diagnosing and treating gastro-intestinal conditions.

Tailored service or set of promotional and commercial services delivered through multiple channels provided to healthcare professionals. intouch.bostonscientiﬁc. eu/s/login

Flexible and personalised programmes of professional educational training, aimed at increasing healthcare professionals competences on BSC technologies and implant procedures. educare.bostonscientiﬁc. eu/s/login

Set of tailored, data driven programmes that we offer to hospitals to help them address financial, clinical and operational challenges. bostonscientific.com/enEU/advantics.html

Social icon

Rounded square Only use blue and/or white. For more details check out our Brand Guidelines.

@BSC_EU_Heart @BSCNeuromodEU

@BSC_Spain @BSC_Neuromod

/company/boston-scientiﬁc

/BostonScientiﬁc

L I F E

H E A L T H C A R E

UNITED PHARMACEUTICAL DISTRIBUTORS SAVING LIVES United Pharmaceutical Distributors (UPD) is proud to enjoy a close association with Life Healthcare, sharing many values such as quality service and excellence. A division of New Clicks South Africa (Pty) Ltd, UPD is South Africa’s leading full line wholesaler and for over 30 years has played a lead and often defining role as a wholesaler and distributor. UPD has a national presence with five strategically placed distribution centres, selling over 20,000 pharmaceutical, surgical and front shop items. The Company is managed and verified to international quality standards relative to supply chain management. UPD distributes to the total healthcare universe including hospitals, independent pharmacies, public sector healthcare facilities, doctors and clinics.

ISO 9001 and ISO 14001 certifications, bringing the organisation in line with international standards. Further evidence of commitment to the patient experience and quality service delivery can be found in the real-time publishing of feedback scores on the Group’s website. Other internal performance reports are also publicly available, adding another layer of transparency. Sound environmental management is also a competitive strength identified by Dr Viranna. “Sustainability is an integral part of how we do business,” he explains. “We therefore identified and implemented four projects in support of the environment. Highlights for the year include the reduction of water usage due to two borehole projects being completed in the Western Cape, installation of solar photovoltaic panels at two of our operations, lighting technology changes and the replacement of evaporative cooling systems. We are all working together for a better, more sustainable world.”

WWW.AFRICAOUTLOOKMAG.COM

Wholesale With its significant market share, UPD is South Africa’s leading pharmaceutical, medical and healthcare wholesaler. UPD supports Life Healthcare when it comes to improving and impacting lives through our high standard quality measures. Distribution Catering for the specialised needs of manufacturers, UPD offers a full order to cash service for branded and generic pharmaceuticals to wholesalers, government institutions andxxxxxxxxx key end Xxxxxxxx xxxxxxxx xxxxxxxxxxx dispenser institutions. Export UPD services over 200 customers in subSaharan Africa, spanning throughout the SADC region. Speciality UPD speciality focuses on oncology and other key specialities requiring a just in time delivery service in the ever evolving face of speciality care.

www.upd.co.za

Xxxxxxxx xxxxxxxx xxxxxxxxxxx xxxxxxxxx

We designed our business around you.

PROFICIENT DRIVEN RESPONSIVE ACCESSIBLE ACCOUNTABLE

Talk to us now: 0860 873 542 www.upd.co.za

Head Office (Johannesburg) | 14 Tamar Avenue, Lea Glen, Roodepoort. PO Box 30128, Wibsey, 1717 | Tel: +27 (0) 11 470 1000 / 0860 873 542 Terms and conditions apply.

L I F E

H E A L T H C A R E

A FORMIDABLE FOOTPRINT

Five-point plan

It is clear that Dr Viranna leads a strong organisation grounded by efficient, patient-centric care and industryleading outcomes. The Life Healthcare Group is committed to building on this legacy and Dr Viranna identified five key focus areas that will maximise the Group’s potential. “The first area is achieving operational excellence through adapting the operating model,” he explains. “Next is driving best-in-class initiatives across the Group through a data-driven and analytical approach. Thirdly, we want to accelerate growth by repositioning our existing assets in line with future growth, expansion of the complementary business range and a global focus on diagnostic growth. The fourth area looks at driving existing quality outcomes, expanding quality initiatives and benchmarking against world-class standards. Finally, we are evolving our operating model by adopting a group-wide integration approach, driving efficiencies, standardisation and synergies.” The Life Healthcare Group is

We are evolving our operating model by adopting a group-wide integration approach, driving efficiencies, standardisation and synergies” embarking on a series of initiatives to deliver on these objectives which, once fulfilled, will see the Company leading the way as an industry standard bearer, both at home and abroad.

Investing in excellence

Several recent investments are helping realise the Group’s goals, best showcased by its research in and adoption of relevant technology. These innovations are transforming the way in which health services

WWW.AFRICAOUTLOOKMAG.COM

The physical presence of the Life Healthcare Group extends across a network of hospitals and acute facilities throughout seven South African provinces, as well as in Botswana. Most of these sites are based in major urban settlements and range from high technology, multi-disciplinary hospitals to community hospitals, sameday surgical centres and niche facilities. The acute business is complemented by nine mental health and seven acute rehabilitation facilities, as well as other services including renal dialysis, oncology and employee health solutions (employer-based occupational health and employee wellness), which currently serves 579,000 individuals. Internationally, the Life Healthcare Group owns Poland’s Scanmed S.A. and UK-based AMG, which has operations in Italy and Ireland and additional activities in Spain, the Netherlands, Germany, Finland, Bulgaria, Austria, France, Norway and Poland.

L I F E

H E A L T H C A R E

are delivered. Globally, the medical technology market, in other words technology used in the diagnosis, monitoring, or treatment of diseases and medical conditions, was worth $405 billion in 2017, a figure estimated to rise to $594.5 billion by 2024. Stereotactic radiosurgery and robotic-assisted surgery are just two examples of the Life Healthcare Group’s most recent investments in this type of innovation. “We have invested in Novalis Tx™ Radiosurgery systems in three of our oncology units,” reveals Dr Viranna. “This technology is one of the most advanced cancer treatment options available and ‘shapes’ the radiation beam to treat the patient’s tumour precisely to deliver the most effective dose of radiation while safeguarding the surrounding healthy tissue.” In the robotics arena, Life Kingsbury Hospital in Cape Town installed the latest version of the Da Vinci surgical

robotic system, a solution which enables surgeons to perform precision surgery that minimises post-operative pain and reduces hospital stay and recovery times, making it the first hospital in Africa to use this technology.

Supplying skills

The Group’s investment in excellence also extends to its most important asset – people. Dr Viranna is acutely aware of the critical nature of South Africa’s shortage in medical skills, highlighting it as one of the greatest challenges facing both the Company and the wider industry. According to World Health Organization (WHO) statistics for 2016, South Africa employed 0.8 physicians and approximately 5.2 nurses per 1,000 citizens, an alarmingly low figure when compared with countries such as Australia, which has around four doctors and 12 nurses per 1,000 citizens.

WWW.AFRICAOUTLOOKMAG.COM

L I F E

H E A L T H C A R E

For the Life Healthcare Group, finding, training and retaining medical talent is essential to its continued success and growth. The Life College of Learning, operating in seven learning centres around the country, has been in operation for 20 years and was established to contribute to South Africa’s pool of skills, especially in the fields of nursing and health science. Last year saw 1,100 students graduate, which reflects the professionalism of the College’s clinical educators, nursing staff and hospital management, as well as the quality of students selected. The College is accredited as a Nursing Education Institution with the South African Nursing Council, the Council on Higher Education and the Department of Higher Education and Training, and is affiliated with the Nelson Mandela University. The centre offers a broad range of courses that cover basic and post-basic courses in nursing, diplomas in midwifery, operating department assistance and health sciences, as well as a variety

For the Life Healthcare Group, finding, training and retaining medical talent is essential to its continued success and growth’ of short learning courses to develop specialised nursing skills. Funding is another vital component in ensuring the country’s medical skills gap is reduced. In light of this, the Life Healthcare Group established the Nursing Education Trust, a body which awards bursaries to student nurses

WWW.AFRICAOUTLOOKMAG.COM

and, similarly, the Life Sub-Specialist Training Fund supports doctors who wish to further their studies. Furthermore, the Group provides bursaries for medical students through a partnership with the Colleges of Medicine of South Africa.

Ensuring accessible healthcare worldwide. With a long legacy of crusading care, our purpose is still to make a difference. Providing sustainable solutions that supports the health of a nation inspires all our plans and drives our actions.

CIPLA MEDPRO (PTY) LTD. Co. Reg. No. 1995/004182/07. Building 9, Parc du Cap, Mispel Street, Bellville, 7530, RSA. Website: www.cipla.co.za Customer Care: 080 222 6662. [1104204]

L I F E

H E A L T H C A R E

SUN PHARMACEUTICAL INDUSTRIES A history of pharmaceutical excellence and innovation Sun Pharmaceutical Industries Ltd is the fourth largest specialty-generic pharmaceutical company in the world. We provide high-quality, affordable medicines which are trusted by healthcare professionals and patients in more than 150 countries globally. Driven by Innovation

The Life Healthcare Group’s doctors are independent healthcare practitioners, and not employees of its hospitals. However, the Group’s doctor partnership model guides how the Company attracts and retains medical talent to build a sustainable doctor succession pipeline. “Relationship building with doctors begins while they are students and registrars at university, and we apply the same principles to attracting doctors as we do to recruiting our own employees by testing for technical skills, cultural fit and values,” explains Dr Viranna. “Once we agree to partner with doctors and provide an opportunity to establish their private practice within our facilities, we build a mutually beneficial, long-term partnership with them by creating an environment in which they enjoy practicing.” Pharmacy is another subsector supported by the Life Healthcare Group through skills development. Through its pharmacist internship programme, the Company provides opportunities for fourth-year

pharmacy students to attain valuable experience, thereby addressing the national and global shortage of pharmacy resources.

Remaining relevant

By supporting and remaining actively involved in the educational forefront of medical innovation, the Life Healthcare Group is able to stay abreast of key local and global trends and react to new developments. The Group’s capacity to research, monitor and anticipate these advances has been developed over time, feeding back into its strategic responses to these trends. Dr Viranna points to a number of current trends which are changing the face of the healthcare industry. “People are living longer,” he says. “Many are living with chronic conditions, and populations are becoming increasingly unhealthy due to sedentary lifestyles, high personal stress levels, and poor dietary habits. This is placing a greater disease burden on healthcare systems. At Life Healthcare, we are seeing increasingly

WWW.AFRICAOUTLOOKMAG.COM

SUN PHARMA invests between six and seven percent of global revenues into research and development. R&D initiatives are led by a strong team of around 2,000 scientists based at our R&D facilities around the world. Sun Pharma is ranked among the top seven generic pharmaceutical companies in South Africa and provides prescription medicines to treat disorders and diseases of the gastro intestinal tract, cardiovascular system, central nervous system as well as anti-infectives, pain products, oncology therapies, ARVs and a range of over the counter products. South Africa SUN PHARMA acquired Ranbaxy in 2014 and today SUN PHARMA South Africa employs 500 people and is made up of four entities: SUN PHARMA (PTY) Ltd, Ranbaxy SA (Pty) Ltd, Ranbaxy Pharmaceuticals (Pty) Ltd and Sonke Pharmaceuticals (Pty) Ltd – the largest supplier of ARV medicines to the South African Government, and an essential partner in controlling the AIDS epidemic. We remain committed to providing affordable pharmaceutical products of global quality standards to patients all over the world.

T +27 (0) 12 643 2000 E shailesh.somvanshi@sunpharma.com

www.sunpharma.com

Touching the lives of every South African under the Sun. GLOBAL FOOTPRINT

EMERGING MARKETS

Our global presence is supported by 42 manufacturing facilities, designed, equipped and operated to meet world class quality standards. As far as sales volumes are concerned: USA accounts for 48% of revenue, India for 26%, developing countries 13% and the rest of world, 13%.

SUN PHARMA is present in over 100 markets with a focus on high-growth emerging markets such as Brazil, Mexico, Russia, Romania, and South Africa and other markets. Our network of over 2 300 sales representatives has enabled us to develop strong relationships with medical professionals and a strong customer focus.

DIVERSIFIED SPECIALITY AND GENERICS PORTFOLIO

DELIVERING VALUE

We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.

Reaching People. Touching Lives.

SUN PHARMAâ€™s multi-cultural workforce, comprises more than 45,000 team members of over 50 nationalities, and is highly motivated in creating additional value for all stakeholders.

L I F E

H E A L T H C A R E

TRANSPHARM

ranspharm Pty Ltd is one of South Africa’s largest pharmaceutical wholesalers and distributors. We are dedicated to providing you top quality products and a world-class service that is needed to ensure your business is a success. Our philosophy is simple – wider range, better prices and quicker deliveries. Transpharm was established by a group of retail pharmacists in 1970 and was acquired by the Shoprite group of companies in 2010. We have relationships with well over 700 suppliers and have more than 30,000 products listed; therefore you are assured that we can service your needs efficiently. We stock ranges including ethical, over the counter, toiletry, veterinary, front shop products, as well as specialist medical and surgical equipment and consumables.

complex cases, both in terms of diagnoses and treatment, and our patients require quality care, not only in acute facilities, but across the entire continuum of care.” Dr Viranna’s observations are supported by research into South Africa’s population. According to Statistics South Africa’s 2018 midyear population estimates, the proportion of people aged 60 and over is increasing – 8.5 percent of South Africans fall into this category, up from 8.1 percent in 2017. Some 24 percent of this demographic live in Gauteng alone, while the country’s overall population has risen 1.55 percent to 57.73 million. In terms of the impact on healthcare delivery, these shifting demographics are creating inevitable cost pressures. “Most global healthcare systems are looking at ways to reduce costs

and improve disease prevention in society,” Dr Viranna explains. “We pride ourselves on our operational efficiency – we work hard to ensure we remain an effective and productive healthcare provider, without ever compromising on our commitment to provide quality patient care. We are already strengthening our offering across the continuum of care to empower patients to take ownership of their health, to support prevention as well as cure in response to both trends.”

Responding to patient demand

The Life Healthcare Group continues to respond to the ever-evolving expectations of patients, who are demanding similarly modern and personalised experiences to those that they are accustomed to in the retail and banking space.

WWW.AFRICAOUTLOOKMAG.COM

In business the only thing more important than your customer is your profit, which is why all of our products are priced to give you substantial returns. As a wholesaler and distributor, we understand the importance of quick and efficient deliveries. That’s why we offer speedy deliveries that range from twice-daily routes in the metro areas of Johannesburg, Pretoria and Cape Town, to next-day deliveries for outlying towns. We service all areas in South Africa. Our deliveries are free of charge, and we do not require a minimum order. So, if you’re looking to improve your business, change to Transpharm – your customers and bottom line will thank you. GAUTENG T 012 377 9000 E clientservice@transpharm.co.za E orders@transpharm.co.za WESTERN CAPE T 021 929 2120 E infowc@transpharm.co.za

www.transpharm.co.za

ONE OF SOUTH AFRICA’S LARGEST MEDICAL WHOLESALERS & DISTRIBUTORS

WE OFFER:

Open a COD or 30 day account now & start placing orders today. Contact us today to start saving! Visit our website or contact our call centre for more information.

• Prescription & Over the Counter Medication • Surgical Equipment & Consumables • Frontshop Products • Veterinary Items • and much more! We offer speedy deliveries that range from twice-daily routes in the metro areas of Johannesburg, Pretoria and Cape Town to next-day deliveries in outlying areas.

GAUTENG:

• Wider range • Better prices • No minimum order values

WESTERN CAPE:

Change to Transpharm Today!

Tel: 012 377 9000 Email: clientservice@transpharm.co.za Email: orders@transpharm.co.za

Tel: 021 929 2120 Email: infowc@transpharm.co.za

Your customers and bottom line will thank you.

www.transpharm.co.za

L I F E

H E A L T H C A R E

FRESENIUS

tanding as a global healthcare group, Fresenius Medical FP has become a crucial player in providing products and services for dialysis, hospitals and the broad medical care of patients at home. The business focuses on enabling the operation of hospitals, whilst simultaneously providing engineering and services for hospitals and other such healthcare facilities. The Fresenius Group itself consists of four business segments, each responsible for its own operations around the world: • Fresenius Medical Care • Fresenius Kabi • Fresenius Helios • Fresenius Vamed

Fresenius Medical Care

In Europe, for example, home-based care is gaining traction, while personalised care, walk-in services and virtual queuing are also becoming popular” Digitalisation of healthcare is thus another trend being closely monitored by Dr Viranna and his team. People are also demanding convenience. “In Europe, for example, homebased care is gaining traction, while personalised care, walk-in services and virtual queuing are also becoming popular,” Dr Viranna observes. “Evaluation and measurement of patient experience has fast become international best practice and assists in ensuring patient-centred care remains a priority for Life Healthcare.” Dr Viranna also highlights how increased levels of connectivity have led to consumers becoming more knowledgeable and eager to compare

quality between healthcare providers. With medical service delivery becoming more transparent, it is more important than ever to be unrelenting in the pursuit of quality service delivery. Several research reports by recognised industry bodies like the World Health Organization point towards the positive impact technology will have on consumer experience and access to treatment. The 2018 Philips Future Healthcare Index, for example, found that technology and digital innovation, artificial intelligence, and connected care will be important enablers of healthcare access despite the impact of rising costs on affordability.

WWW.AFRICAOUTLOOKMAG.COM

Equally, Fresenius Medical Care is an alternative arm of the company and one of the world’s leading providers of products and services for patients with chronic kidney failure. For over 20 years, the firm has been operating at all levels of care, acting as a standard setter within the renal dialysis segment, operating over 3,700 centres in 50 countries across the globe. Having established such an extensive footprint, the company now provides tailor-made therapy options for roughly 320,000 patients, dedicated to improving people’s lives.

NephroCare NephroCare stands under the Fresenius Medical Care umbrella, providing services in dialysis centres in more than 30 countries throughout four continents. Having opened the doors to its first centre a quarter of a century ago, the division now serves more than 100,000 patients globally, providing roughly 13 million treatments per year. Through an emphasis on state-of-the-art centres and technologies, NephroCare’s enormous growth is expected to continue moving forward.

Creating a future worth living for patients worldwide, every day.

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 3.2 million patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure. We care for more than 329,000 patients in our global network of more than 3,800 dialysis clinics. At the same time, we operate 41 production sites on all continents, to provide dialysis products such as

dialysis machines, dialyzers and related disposables. Our strategy is geared toward sustainable growth. We aim to continuously improve the quality of life of patients with kidney disease by offering innovative products and treatment concepts of the highest quality. Fresenius Medical Care’s corporate headquarters are in Bad Homburg v.d.H., Germany. The headquarters of North America are in Waltham, Massachusetts and the headquarters of Asia-Pacific are located in Hong Kong.

FRESENIUS MEDICAL CARE Else-Kröner-Str. 1 61352 Bad Homburg, Germany

www.freseniusmedicalcare.com

WWW.AFRICAOUTLOOKMAG.COM

L I F E

H E A L T H C A R E

PFIZER SOUTH AFRICA

fizer South Africa was first established in South Africa (SA) in 1953 and with its vision of “living our full potential in striving for a healthier Southern Africa”, it embraces its dream of being able to see every Southern African citizen having access to quality healthcare.

85 Bute Lane Sandton 2146 T 0860 Pfizer (734937)

www.pfizer.co.za “One area already benefitting from technological advancements at Life Healthcare, which we will continue to grow, is diagnostic imaging,” says Dr Viranna. “Making use of smarter technology like this means healthcare providers can enhance the patient experience by lowering the risk of diagnostic errors while speeding up the provision of better, more affordable treatment.”

During our partnership, to strengthen the SANCB’s vehicle fleet, which visits hospitals in rural areas, we have donated three mobile units fitted with the latest ophthalmic”

Social responsibility

While investing in cutting-edge technology enables the Life Healthcare Group to better serve patients at its facilities, the Company also recognises the importance of having a positive impact on the wider society outside of its hospitals and medical centres. The Group plays to its strengths and focuses on health and education in its community activities, complementing the work it already does to help build a healthier South African population. According to Dr Viranna, social

investment is a moral responsibility and an essential aspect of good corporate citizenship. To illustrate this, the Group CEO explains Life Healthcare’s 12-year partnership with the South African National Council

WWW.AFRICAOUTLOOKMAG.COM

for the Blind (SANCB). “During our partnership, to strengthen the SANCB’s vehicle fleet, which visits hospitals in rural areas, we have donated three mobile units fitted with the latest ophthalmic.”

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. For us, the patient always comes first We are committed to discovering, developing, manufacturing and delivering innovative products that may change the outcome of chronic conditions and devastating diseases. Our vast portfolio of trusted, quality medicines helps people at every stage of life – from prevention to treatment to wellness. Thanks to the breadth and depth of our global reach and capabilities, we are able to anticipate customer and patient needs and make a meaningful contribution to improving global health.

key to sustaining our growth and profitability. As such, the quest for innovative solutions invigorates the Pfizer community worldwide and we have more than 200 new R&D collaborations active worldwide. Our partnerships Pfizer works closely with stakeholders and healthcare professionals across the healthcare sector, as well as with government on key issues impacting the pharmaceutical industry. We are committed to making a difference and build partnerships in communities to strengthen health systems, increase access to our medicines, and find sustainable solutions to the health challenges of today, and tomorrow.

support our communities’ most vulnerable members, including children, women and the elderly. Pfizer’s corporate responsibility activities are focused on investing the full range of our resources - people, skills, expertise and funding - to broaden access to medicines and strengthen healthcare delivery for underserved people around the world.

Our communities At Pfizer we have a proud tradition of ensuring that the communities in which we live and work benefit from our investment through unique partnerships. Throughout the world, Pfizer contributes to local charitable programmes that provide health care in poor urban and rural areas; and we

Our Innovation Research and development (R & D) is at the heart of fulfilling our purpose to help people live healthier lives. Innovation is also the

PFIZER, DEDICATED TO HELPING SOUTH AFRICANS LIVE HEALTHIER LIVES

OrbusNeich is a global pioneer in the development of life-changing vascular solutions, offering an extensive portfolio of products that set industry benchmarks for vascular intervention. Our proprietary EPC Capturing Technology is featured on the world’s first and only dual therapy stent, COMBO™. This industryleading stent is designed to repair vessel injury and regenerate endothelium fostering natural vessel healing.

Our Products Forging new paths in the treatment of vascular diseases, our range of innovative devices include an extensive portfolio of high-performance stents and balloons.

www.orbusneich.com

WWW.AFRICAOUTLOOKMAG.COM

L I F E

H E A L T H C A R E

SAFMED

afMed has been providing key solutions to the South African healthcare industry for over 30 years with products and services that meet the market’s changing needs. We recognise the challenges facing our partners in the healthcare market. In order to provide sustainable solutions, we offer quality products and services to improve efficiencies within the operating theatre, CSSD and endoscopy environments.

Visit our website or contact us below: E info@safmed.co.za F www.facebook.com/Safmed.SA/ T https://www.twitter.com/safmedsa

www.safmed.co.za Over the past 12 years, the partnership has screened more than 56,000 patients, performed 15,000 cataract surgical procedures, dispensed more than 13,000 pairs of prescription glasses, referred 9,000 other cases for medical treatment, detected almost 1,700 cases of glaucoma, and sponsored 66 cataract surgery tours, delivering between 40 and 60 procedures per tour. The Life Healthcare Group donated a further R12 million to the SANCB Optima College, a nationallyrecognised centre of excellence which upskills visually impaired adults to assist them in finding job placements. The Optima College was established in 1985 in Pretoria, and remains one of few education institutions catering exclusively to blind and partially sighted persons. Among the courses offered are computer literacy, contact centre training and braille literacy, while daily life skills are also nurtured through specialised classes designed to enable independent living.

Contributing to NHI

One issue private organisations and governments are working hard to address is the challenge of inequality in the delivery of healthcare services. A key part of South Africa’s National Development Plan 2030 (NDP) involves the implementation of the National Health Insurance (NHI) scheme, which proposes universal healthcare for all citizens and long-term residents of South Africa, regardless of their employment status or their ability to make a direct monetary contribution to the fund. For Dr Viranna, working with public authorities in this way is a matter of duty. “Life Healthcare is acutely aware of the inequality in healthcare delivery in South Africa,” he says. “We have embraced the government’s NHI proposition which promulgates access to universal healthcare for all South Africans. Given the complex health challenges facing our country, we strongly believe South

WWW.AFRICAOUTLOOKMAG.COM

Your solutions partner for 30 YEARS

We specialise in providing solutions and products that improve the productivity and effectiveness in the CSSD, Operating Theatre & Endoscopy Unit. From expert advice on new theatre or CSSD designs to providing the latest digital operating theatre and instrument tracking technology, we have the products and experience to offer meaningful value to our customers.

Process Improvement

Track, Trace & Asset Management

Gauteng, Mpumalanga, Limpopo & North West T el: 011 201 4300

EDUCATION Digital Theatre Systems

Kwa-Zulu Natal T el: 082 464 3832

CSSD & Operating Theatre Design Advice

Online & Classroom Based Education

Western & Eastern Cape T el: 021 763 3280

In the business of saving lives

Sterility Assurance

Customized Service Programs

Decontamination

Free State & Northern Cape T el: 082 686 8075

E -mail: info@s afmed.co.za Webs ite: www.s afmed.co.za www.facebook.com/Safmed.SA/ T witter: @SafMedSA

FACE SHIELDS PURPLE NITRILE* MAX Gloves NEW

NEW

FORMERLY KIMBERLY- CLARK HEALTH CARE

OT E

C T

Plot 61127, Block 8, Gaborone, Botswana E-mail: info@medswana.co.bw Tel: (+267) 39 59930 / 3985200 Fax: (+267) 39 57911 / 3985290

www.medswana.co.bw

S EL

• conventional medicine • warehousing • herbal care • distribution • regulatory affairs • veterinary • surgical • fitness & nutrition • first aid • baby care • cosmetics

N ATIE RP

products

U YO

services

Medswana is a fully licensed pharmaceutical wholesaler and distributor that exists to facilitate access to medical products throughout Botswana, through partnerships with both the public and private sector.

E OT PR

WHAT WE DO

THE RIGHT LEVEL OF PROTECTION FOR YOUR NEEDS NEW

F NEW

QUICK CHECK INTERLEAVED* Sequential Sterilisation wrap

SMART-FOLD* Sterilisation packaging

WWW.AFRICAOUTLOOKMAG.COM

L I F E

H E A L T H C A R E

African healthcare providers have a moral obligation to work with the government to find solutions for the issues facing our country. We are committed to making our contribution towards achieving the important health objectives enshrined in our country’s NDP.” The Life Healthcare Group recognises the scale of the task ahead to reduce the healthcare gap. World Bank research demonstrates that in 2015, more than a third of South Africa’s poorest citizens lived at least 20 kilometres from a hospital, 27 percentage points higher than the wealthiest segment of the population. The NHI is designed to address this disparity, and the Company is determined to contribute towards the implementation of this policy. “We believe that the NHI will increase access to quality healthcare for all South Africans and, additionally, align South Africa with many international healthcare systems,” Dr

We believe that the NHI will increase access to quality healthcare for all South Africans and, additionally, align South Africa with many international healthcare systems” Viranna explains. “We have gained valuable experience through our international operations, where government-led healthcare systems are the norm.” The Life Healthcare Group has taken the time to understand the challenges facing healthcare in South Africa. Concerning implementation thereof, the Group has taken a long-term view of investing in the opportunities the NHI will inevitably present. “Essentially,” Dr Viranna adds, “we focus on how best Life Healthcare can support the government’s vision of achieving universal healthcare in

WWW.AFRICAOUTLOOKMAG.COM

South Africa and, therefore, we have aligned our business imperatives accordingly.”

Advancing access

Looking ahead, in addition to assisting with the implementation of NHI, Dr Viranna is looking to futureproof the business by delivering on his five key objectives in the short term. He reiterates his desire to further diversify the Life Healthcare Group into a full-spectrum healthcare services provider, both at home and across the wider region: “We will continue to expand more aggressively

Shaping the future of healthcare

At Siemens Healthineers, our purpose is to enable healthcare providers to increase value. We do this by empowering them on their journey towards expanding precision medicine, transforming care delivery and improving patient experience, all enabled by digitalizing healthcare. An estimated five million patients globally everyday benefit from our innovative technologies and services in the areas

of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 170 years of experience and 18,000 patents globally. With about 50,000 dedicated colleagues in over 70 countries, we will continue to innovate and shape the future of healthcare.

Customer Care Centre: +27 80 002 4311 www.healthcare.siemens.co.za

into complementary services and businesses to achieve our aspiration of transitioning from a predominantly hospital business to an internationally diversified healthcare provider, offering a compelling range of services.” In terms of the Life Healthcare Group’s domestic market, the focus will be on growing new services and launching products that cater to segments not currently served. For Dr Viranna, this all circles back to

contributing to the betterment of South African healthcare delivery. Indeed, the Life Healthcare Group recognises the importance of continually innovating and challenging assumptions to remain future-fit and deliver on its aspiration of improving the accessibility and affordability of quality healthcare. “From a clinical perspective, we will have realigned our business model and moved closer to achieving our

objective of becoming a clinically-led organisation,” says Dr Viranna. “This will be reflected in enhanced quality scores and patient outcomes.”

Tel: +27 11 219 9000 life.communications@lifehealthcare.co.za

www.lifehealthcare.co.za

WWW.AFRICAOUTLOOKMAG.COM

21 Chaplin Rd, Illovo, 2196, South Africa Tel: +27 11â€¯219 9000 life.communications@lifehealthcare.co.za www.lifehealthcare.co.za